Navigation Links
Mahdhani to get ayurvedic treatment in prison

The Tamil Nadu government has directed the state prisons department to provide ayurvedic treatment to Kerala-based PDP leader and a key accused in the 1998// serial blasts Abdul Nasser Mahdhani in the central prison here.

Mahdhani, lodged in the prison after his arrest in March 1998, 45 days after the serial blasts, which claimed 52 lives, is said to be suffering from blood pressure, diabetes, spinal proble and weight loss. He also uses an artifical limb, having lost his right leg in a blast in Kerala.

Though Mahdhani has pleaded for parole or bail to undergo treatment in any private hospital in Coimbatore or Kerala, the Tamil Nadu government had issued a 'Movement Restriction Order', citing the need for him to be present for speedy trial in the serial blast case at the special court here.

With various organisations and political parties in Kerala and even the Kerala Assembly passing a resolution, seeking bail and good medical care for Mahdhani on humanitarian grounds, Kerala Chief Minister V S Achuthanandan met his Tamil Nadu counterpart M Karunanidhi recently and discussed the issue.

After sending medical teams to examine Madhani and holding discussions with those concerned, the Tamil Nadu government has directed the prison authorities to arrange ayurvedic treatment in the prison itself, jail sources said.

A special team from a leading ayurvedic hospital in the city was likely to start the treatment to Mahdhani in a couple of days, the sources added.
'"/>




Page: 1

Related medicine news :

1. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Feeding channel created by malaria parasite - a new target for malaria treatments
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology: